Home › Trial NCT01164176
Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer
- Trial IDNCT01164176
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorYonsei University
- Enrollment40
- Start date2010-03
- ConditionsHead and Neck Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.